Summaries for patients. Rosiglitazone treatment for fat redistribution and metabolic abnormalities caused by anti-HIV therapy
- PMID: 15148089
- DOI: 10.7326/0003-4819-140-10-200405180-00003
Summaries for patients. Rosiglitazone treatment for fat redistribution and metabolic abnormalities caused by anti-HIV therapy
Comment on
-
Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized, controlled trial.Ann Intern Med. 2004 May 18;140(10):786-94. doi: 10.7326/0003-4819-140-10-200405180-00008. Ann Intern Med. 2004. PMID: 15148065 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical